Werfen North America

Last chance to register for today's educational webinar “Connective Tissue Diseases: Advancing Diagnosis Through Biomarkers and Technology” https://hubs.ly/Q037KYV-0 This webinar is eligible for PACE credit fulfillment and covers how to: ? Recognize the different markers in the various subsets of connective tissue disease, especially the most common markers found and the overlap or exclusivity of biomarkers in these conditions ? Differentiate between various protein sources used in different diagnostic methods ? Prepare and further explain the expectations for inter-method variation #Autoimmunity #CTD #PACECredit #AutoimmuneDiagnostics | The level of instruction is intermediate.

Still time to register for tomorrow's educational webinar, “Connective Tissue Diseases: Advancing Diagnosis Through Biomarkers and Technology” https://hubs.ly/Q037K_kK0 This webinar is eligible for PACE credit fulfillment and covers how to: ? Recognize the different markers in the various subsets of connective tissue disease, especially the most common markers found and the overlap or exclusivity of biomarkers in these conditions ? Differentiate between various protein sources used in different diagnostic methods ? Prepare and further explain the expectations for inter-method variation #Autoimmunity #CTD #PACECredit #AutoimmuneDiagnostics | The level of instruction is intermediate.

Please be aware, Werfen has been alerted to a scam involving fraudulent requests for interviews via personal emails (not LinkedIn Messages). Please know that any emails from Werfen will have the @werfen.com email extension and any interview requests will always be via a Microsoft Teams link.

Have you registered for next week's educational webinar, “Connective Tissue Diseases: Advancing Diagnosis Through Biomarkers and Technology” featuring Chelsea Bentow, Sr. Manager, Biomarker Discovery and Early Development, R&D, Werfen. Don’t wait! There is still time to register: https://hubs.ly/Q037L1j40 This webinar is eligible for PACE credit fulfillment and covers how to: ? Recognize the different markers in the various subsets of connective tissue disease, especially the most common markers found and the overlap or exclusivity of biomarkers in these conditions ? Differentiate between various protein sources used in different diagnostic methods ? Prepare and further explain the expectations for inter-method variation #Autoimmunity #CTD #PACECredit #AutoimmuneDiagnostics | The level of instruction is intermediate.

In recognition of Patient Safety Awareness Week, we want to shine a light on hemolysis and the importance of detecting it. Hemolysis, the #1 source of preanalytical error1, while prevalent throughout the hospital, is often unrecognized. This can negatively impact potassium K+ results and patient care.2 #PatientSafety #PSAW2025 #SaferCare Check out this story to learn how UK HealthCare is using the latest technology to help detect hemolysis at the point of care. https://hubs.ly/Q038q4v30 __________ 1. Lippi G, von Meyer A, Cadamuro J, Simundic A-M. Blood sample quality. Diagnosis. 2018;6(1):25–31. doi:10.1515/dx-2018-0018. 2. Lippi G, Salvagno GL, Favaloro EJ, Guidi GC. Survey on the prevalence of hemolytic specimens in an academic hospital according to collection facility: opportunities for quality improvement. Clin Chem Lab Med. 2009;47(5):616–618. doi:10.1515/CCLM.2009.132.

Bleeding disorders impact the body's ability to control blood clotting. We're proud to offer #POC and laboratory instruments, reagents, and digital solutions that aid in diagnosing and treating thrombotic and #bleedingdisorders. | #BDAM #hematology Learn more ?https://hubs.ly/Q037XDwm0

Join us for this in-person event with Christopher Farnsworth, PhD, Assoc. Prof., Dept. of Pathology & Immunology at @Washington University School of Medicine. The presentation will focus on challenges of managing hemolysis at the point of care. March 25, 2025. Registration required. https://hubs.ly/Q039jsLP0 #MedicalLaboratory #DiagnosticTesting #HemolysisDetection

Don’t wait! There is still time to register for our Autoimmunity Speaker Series taking place on March 19th. Join us for a presentation on “Connective Tissue Diseases: Advancing Diagnosis Through Biomarkers and Technology” featuring Chelsea Bentow, Sr. Manager, Biomarker Discovery and Early Development, R&D, Werfen. https://hubs.ly/Q037KWBk0 This webinar is eligible for PACE credit fulfillment and covers how to: ? Recognize the different markers in the various subsets of connective tissue disease, especially the most common markers found and the overlap or exclusivity of biomarkers in these conditions ? Differentiate between various protein sources used in different diagnostic methods ? Prepare and further explain the expectations for inter-method variation #Autoimmunity #CTD #PACECredit | The level of instruction is intermediate.

The José María Rubiralta Award, our company’s highest and most prestigious recognition, is given annually in honor of our founder, José María Rubiralta. The award acknowledges special contributions?to our business highlighting the values of effort, accountability and commitment. The?2024 J.M. Rubiralta?Award?recognizes and celebrates the outstanding contributions of Dr. Catalina Pérez-K?ller. In 2016, Catalina launched the Clinical and Market Access program in Latin America, boosting specialization and awareness of our Hemostasis, Acute Care Diagnostics, and Autoimmunity solutions. She was instrumental in Mexico’s 2023-2025 IMSS tender, driving a significant increase in D-Dimer assay. She also led a regional clinical campaign that expanded D-Dimer adoption, maintaining high usage - even surpassing pre-pandemic levels. Catalina also has a knack for identifying and developing key talent. Many congratulations Catalina Perez koller. Your passion, dedication, and hard work have made a difference for our company and the many patients who benefit from your efforts. Thank Catalina for your outstanding contributions - here’s to your continued success. ?????

Bleeding disorders impact the body's ability to control blood clotting. We're proud to offer #POC and laboratory instruments, reagents, and digital solutions that aid in diagnosing and treating thrombotic and #bleedingdisorders. | #BDAM #hematology Learn more ?https://hubs.ly/Q037XDwm0